Premier Perspectives The blog for insider insights in clinical development Consulting Orphan Drug Designation: When Is It Appropriate, and How Does It Apply to Orphan Subsets? By Vanessa Atayde September 5, 2023 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today